Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial 
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
Upturn AI SWOT - About
SSKN 
STRATA Skin Sciences Inc (SSKN)
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
09/17/2025: SSKN (1-star) is currently NOT-A-BUY. Pass it for now.
Upturn Star Rating
Not Recommended Performance
These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.
Number of Analysts
2 Analysts rated it
Very few follow this stock; limited insights, higher-risk early investing.
1 Year Target Price $8
1 Year Target Price $8
| 1 | Strong Buy |
| 1 | Buy |
| 0 | Hold |
| 0 | Sell |
| 0 | Strong Sell |
Analysis of Past Performance
Type Stock | Historic Profit -5.92% | Avg. Invested days 13 | Today’s Advisory PASS |
Upturn Star Rating | Upturn Advisory Performance  1.0 | Stock Returns Performance  1.0 |
| Profits based on simulation | Last Close 09/17/2025 |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 7.38M USD | Price to earnings Ratio - | 1Y Target Price 8 |
Price to earnings Ratio - | 1Y Target Price 8 | ||
Volume (30-day avg) 2 | Beta 0.56 | 52 Weeks Range 1.38 - 3.86 | Updated Date 09/17/2025 |
52 Weeks Range 1.38 - 3.86 | Updated Date 09/17/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) -2.84 |
Analyzing Revenue: Products, Geography and Growth
Revenue by Products
Product revenue - Year on Year
Revenue by Geography
Geography revenue - Year on Year
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin -35.13% | Operating Margin (TTM) -29.02% |
Management Effectiveness
Return on Assets (TTM) -11.13% | Return on Equity (TTM) -235.41% |
Valuation
Trailing PE - | Forward PE - | Enterprise Value 17763191 | Price to Sales(TTM) 0.22 |
Enterprise Value 17763191 | Price to Sales(TTM) 0.22 | ||
Enterprise Value to Revenue 0.54 | Enterprise Value to EBITDA -7008.83 | Shares Outstanding 5268710 | Shares Floating 1496279 |
Shares Outstanding 5268710 | Shares Floating 1496279 | ||
Percent Insiders 10.13 | Percent Institutions 57.24 |
Upturn AI SWOT
STRATA Skin Sciences Inc
Company Overview
History and Background
STRATA Skin Sciences, Inc. (formerly PhotoMedex, Inc.) was founded in 1989. It focuses on developing and commercializing innovative products for the treatment of dermatological conditions. Initially focused on lasers for medical and aesthetic uses, it has evolved through acquisitions and internal development to offer a range of dermatology solutions.
Core Business Areas
- Dermatology Devices: STRATA Skin Sciences develops, manufactures, and markets medical devices used by dermatologists and other healthcare professionals for the treatment of skin conditions, including psoriasis, vitiligo, and acne.
- Pharmaceutical Products: While primarily a device company, STRATA also offers pharmaceutical products related to dermatology.
Leadership and Structure
STRATA Skin Sciences is led by a management team with experience in the medical device and dermatology industries. The organizational structure includes departments for research and development, manufacturing, sales and marketing, and finance.
Top Products and Market Share
Key Offerings
- XTRAC excimer laser: XTRAC is a laser system used to treat psoriasis and vitiligo. It's a key revenue driver for STRATA. Market share data is difficult to pinpoint precisely due to the fragmented nature of the dermatology device market, but XTRAC is a significant player in targeted phototherapy. Competitors include device manufacturers offering similar laser or light-based therapies, such as TheraBeam.
- Rhytidend: Rhytidend is a topical cream that diminishes fine lines and wrinkles. Market share data is not readily available. The competitors for this product are companies like Allergan, Galderma and other companies selling topical creams.
Market Dynamics
Industry Overview
The dermatology device market is characterized by innovation and demand for effective treatments for skin conditions. The market is competitive, with several players offering a variety of solutions, including lasers, light-based therapies, and topical treatments. Increasing awareness of skin health and aging drives market growth.
Positioning
STRATA Skin Sciences is positioned as a provider of targeted phototherapy and other dermatological solutions. Its competitive advantages include its established XTRAC technology and its relationships with dermatologists.
Total Addressable Market (TAM)
The global dermatology devices market is projected to reach hundreds of billions of dollars. STRATA is positioned to capture a share of this market, particularly in the targeted phototherapy segment. TAM estimates are unavailable.
Upturn SWOT Analysis
Strengths
- Established XTRAC technology
- Relationships with dermatologists
- Focus on targeted phototherapy
Weaknesses
- Limited product portfolio compared to larger competitors
- Financial performance can be volatile
- Reliance on XTRAC sales
Opportunities
- Expansion into new geographic markets
- Development of new dermatological solutions
- Acquisitions of complementary technologies or products
Threats
- Competition from larger medical device companies
- Technological advancements rendering existing products obsolete
- Changes in healthcare regulations or reimbursement policies
Competitors and Market Share
Key Competitors
- PDCO
- ALGN
- LIVN
Competitive Landscape
STRATA Skin Sciences faces intense competition from larger medical device companies with broader product portfolios and greater financial resources. Its competitive advantage lies in its established XTRAC technology, but it needs to continue innovating to maintain its position.
Growth Trajectory and Initiatives
Historical Growth: STRATA's growth has been driven by sales of the XTRAC laser and acquisitions. However, growth can fluctuate due to market conditions and competition.
Future Projections: Analyst estimates are unavailable to complete.
Recent Initiatives: Recent strategic initiatives often involve expanding sales efforts, developing new products, or acquiring complementary businesses. Up-to-date data is needed to complete.
Summary
STRATA Skin Sciences is a niche player in the dermatology device market, primarily known for its XTRAC laser. While XTRAC provides a strong revenue stream, the company needs to diversify its product offerings and expand its market reach to sustain long-term growth. Competition from larger companies remains a significant challenge, requiring continuous innovation and strategic acquisitions to maintain its market position. The lack of dividend payouts and variable shareholder returns add to the risk profile.
Peer Comparison
Sources and Disclaimers
Data Sources:
- Company website
- SEC filings
- Market research reports (placeholder)
- Financial news sources (placeholder)
Disclaimers:
This analysis is based on publicly available information and is not financial advice. Market share data is estimated and may not be precise. Placeholder financial data used.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About STRATA Skin Sciences Inc
Exchange NASDAQ | Headquaters Horsham, PA, United States | ||
IPO Launch date 2005-10-28 | President, CEO & Vice-Chairman Dr. Dolev Rafaeli Ph.D. | ||
Sector Healthcare | Industry Medical Devices | Full time employees 106 | |
Full time employees 106 | |||
STRATA Skin Sciences, Inc., a medical technology company, develops, commercializes, and markets products for the treatment of dermatologic conditions in the United States, China, Europe, the Middle East, Asia, Australia, South Africa, and Central and South America. It operates through two segments, Dermatology Recurring Procedures and Dermatology Procedures Equipment. The company offers XTRAC excimer laser and VTRAC lamp systems, which are used in the treatment of psoriasis, vitiligo, and other skin conditions; and TheraClear acne therapy system for the treatment of mild to moderate inflammatory, comedonal, and pustular acne. It serves dermatologists and dermatological group clinics. The company was formerly known as MELA Sciences, Inc and changed its name to STRATA Skin Sciences, Inc. in January 2016. STRATA Skin Sciences, Inc. was incorporated in 1989 and is headquartered in Horsham, Pennsylvania.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.